| Innate or adaptive immunity? The example of natural killer cells E Vivier, DH Raulet, A Moretta, MA Caligiuri, L Zitvogel, LL Lanier, ... science 331 (6013), 44-49, 2011 | 3315 | 2011 |
| Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis A Moretta, C Bottino, M Vitale, D Pende, C Cantoni, MC Mingari, ... Annual review of immunology 19 (1), 197-223, 2001 | 2249 | 2001 |
| Guidelines for the use of flow cytometry and cell sorting in immunological studies A Cossarizza, HD Chang, A Radbruch, A Acs, D Adam, S Adam‐Klages, ... European journal of immunology 49 (10), 1457-1973, 2019 | 1993 | 2019 |
| Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule C Bottino, R Castriconi, D Pende, P Rivera, M Nanni, B Carnemolla, ... The Journal of experimental medicine 198 (4), 557-567, 2003 | 1117 | 2003 |
| Receptors for HLA class-I molecules in human natural killer cells A Moretta, C Bottino, M Vitale, D Pende, R Biassoni, MC Mingari, ... Annual review of immunology 14 (1), 619-648, 1996 | 1088 | 1996 |
| Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells D Pende, S Parolini, A Pessino, S Sivori, R Augugliaro, L Morelli, ... Journal of Experimental Medicine 190 (10), 1505-1516, 1999 | 1064 | 1999 |
| NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non–major histocompatibility complex–restricted tumor cell lysis M Vitale, C Bottino, S Sivori, L Sanseverino, R Castriconi, E Marcenaro, ... The Journal of experimental medicine 187 (12), 2065-2072, 1998 | 996 | 1998 |
| Human bone marrow–derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms ME Bernardo, N Zaffaroni, F Novara, AM Cometa, MA Avanzini, A Moretta, ... Cancer research 67 (19), 9142-9149, 2007 | 964 | 2007 |
| Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor H Ikeda, B Lethé, F Lehmann, N Van Baren, JF Baurain, C De Smet, ... Immunity 6 (2), 199-208, 1997 | 953 | 1997 |
| Natural killer cells and dendritic cells: rendezvous in abused tissues A Moretta Nature Reviews Immunology 2 (12), 957-965, 2002 | 899 | 2002 |
| Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a … R Maccario, M Podesta, A Moretta, A Cometa, P Comoli, D Montagna, ... Haematologica 90 (4), 516-525, 2005 | 876 | 2005 |
| The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans CS Brandt, M Baratin, EC Yi, J Kennedy, Z Gao, B Fox, B Haldeman, ... Journal of Experimental Medicine 206 (7), 1495-1503, 2009 | 872 | 2009 |
| Transforming growth factor β1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells R Castriconi, C Cantoni, M Della Chiesa, M Vitale, E Marcenaro, R Conte, ... Proceedings of the National Academy of Sciences 100 (7), 4120-4125, 2003 | 868 | 2003 |
| Unravelling natural killer cell function: triggering and inhibitory human NK receptors L Moretta, A Moretta The EMBO journal 23 (2), 255-259, 2004 | 822 | 2004 |
| Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity A Pessino, S Sivori, C Bottino, A Malaspina, L Morelli, L Moretta, ... The Journal of experimental medicine 188 (5), 953-960, 1998 | 755 | 1998 |
| The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic G Ferlazzo, D Thomas, SL Lin, K Goodman, B Morandi, WA Muller, ... The Journal of Immunology 172 (3), 1455-1462, 2004 | 747 | 2004 |
| Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity E Mamessier, A Sylvain, ML Thibult, G Houvenaeghel, J Jacquemier, ... The Journal of clinical investigation 121 (9), 3609-3622, 2011 | 745 | 2011 |
| p46, a novel natural killer cell–specific surface molecule that mediates cell activation S Sivori, M Vitale, L Morelli, L Sanseverino, R Augugliaro, C Bottino, ... The Journal of experimental medicine 186 (7), 1129-1136, 1997 | 726 | 1997 |
| Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra-and intracellular domains N Wagtmann, R Biassoni, C Cantoni, S Verdiani, MS Malnati, M Vitale, ... Immunity 2 (5), 439-449, 1995 | 708 | 1995 |
| Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to … D Pende, P Rivera, S Marcenaro, CC Chang, R Biassoni, R Conte, ... Cancer research 62 (21), 6178-6186, 2002 | 704 | 2002 |
Lorenzo MorettaBambino Gesù Children’s Hospital, IRCCSEmail verificata su opbg.net